Johns Hopkins researchers have invented a new class of cancer immunotherapy drugs that are more effective at harnessing the power of the immune system to fight cancer. This new approach, which was reported in Nature Communications, results in a significant decrease of tumor growth, even against cancers that do not respond to existing immunotherapy.
http://ift.tt/2HVF4Fz
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου